Cargando…
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
BACKGROUND: A new entity of patients with recurrent prostate cancer limited to a small number of active metastatic lesions is having growing interest: the oligometastatic patients. Patients with oligometastatic disease could eventually be managed by treating all the active lesions with local therapy...
Autores principales: | Pasqualetti, Francesco, Panichi, Marco, Sainato, Aldo, Matteucci, Fabrizio, Galli, Luca, Cocuzza, Paola, Ferrazza, Patrizia, Coraggio, Gabriele, Pasqualetti, Giuseppe, Derosa, Lisa, Sollini, Martina, Mannelli, Lorenzo, Ortori, Simona, Monzani, Fabio, Ricci, Sergio, Greco, Carlo, Fabrini, Maria Grazia, Erba, Paola Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722628/ https://www.ncbi.nlm.nih.gov/pubmed/26796633 http://dx.doi.org/10.1186/s13014-016-0586-x |
Ejemplares similares
-
[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019) -
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series
por: Sollini, Martina, et al.
Publicado: (2016) -
[(18)F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer
por: Sollini, Martina, et al.
Publicado: (2021) -
Radiomics-Based Inter-Lesion Relation Network to Describe [(18)F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer
por: Cavinato, Lara, et al.
Publicado: (2023) -
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature
por: Delishaj, Durim, et al.
Publicado: (2017)